Tag Archive for: life sciences investment

BIO-Europe C-Suite Survey: Biopharma dealmaking set to accelerate, but investor caution still caps ambition

75% of biopharma leaders expect partnering and M&A appetite to increase over the next 12 months, none expect a decline 69% expect access to capital to improve, yet 79% identify investor risk aversion as the biggest constraint on biotech investment 52% say US policy uncertainty has made Europe more attractive to build and partner in, […]

Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program

Financing will be used to advance Rewind’s lead oral program designed to promote remyelination and restore neurological function Peer-reviewed data published in PLOS ONE demonstrated remyelination and functional recovery following oral treatment with a selective GPR17 antagonist in preclinical models Leuven, Belgium – 6 October 2026 – Rewind Therapeutics (“Rewind”), a biotechnology company developing small-molecule […]

Asabys Partners Integrates Aliath Bioventures Life Sciences Investment Platform in Strategic Move with AltamarCAM

Strategic integration fuels Asabys’ goal to build a beyond €1 billion life sciences investment platform in Europe by 2030 Asabys incorporates Aliath Bioventures’ experienced team with a successful track record Alta Life Sciences Spain I FCR fund to be co-managed by Asabys and AltamarCAM MADRID and BARCELONA, Spain, Oct. 2, 2025 – Asabys Partners, a Spanish venture […]

© Optimum Strategic Communications.